Illustration of Parkinson’s disease which makes the brain gradually loosing dopaminergic neurons like a tree its leaves.
Illustration of Parkinson's disease which makes the brain gradually loosing dopaminergic neurons like a tree its leaves. Silvia Arber - group leader at the FMI and at the Biozentrum, University of Basel - and a team of international experts receive 8 million Swiss Francs from the Aligning Science Across Parkinson's (ASAP) initiative to investigate Parkinson's. The aim is to uncover how the early stages of this disease impact the activities of neuronal circuits regulating movement and sleep. The results may lead to earlier diagnoses and therapies. The new project funded by ASAP brings together researchers from the FMI, the Biozentrum of the University of Basel, and the US-based universities Northwestern, Columbia, Berkeley and Stanford. "Each team selected for the Collaborative Research Network brings unique expertise and perspective to ASAP's mission of tackling key knowledge gaps in disease understanding through open science," says ASAP managing director Ekemini Riley. Such research will help to better understand the disease and could lead to much earlier diagnosis and therapies for Parkinson's.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
